Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748018 · ClinicalTrials.gov registry record · NA
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 959
- Enrollment target
NCT02748018: Completed NA study, sponsored by Medtronic MiniMed.
NCT02748018 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 959 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748018, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 959 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Interventions
- DEVICE 670G and 770G Insulin Pump
- DEVICE Subject's Current Diabetes Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 959 participants |
| Start Date | 2017-05-25 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748018
The ClinicalTrials.gov registry entry for NCT02748018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 959 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 670G and 770G Insulin Pump is the first listed.
NCT02748018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02748018 about?
NCT02748018 is a clinical study titled "Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home". The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range f...
What is the current status of trial NCT02748018?
This trial is currently completed. It is a NA study. The enrollment target is 959 participants. The study started on 2017-05-25. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT02748018?
The interventions under investigation include: 670G and 770G Insulin Pump (DEVICE), Subject's Current Diabetes Therapy (DEVICE).
Who is sponsoring clinical trial NCT02748018?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.